Antiphospholipid Syndrome Program
The Yale Antiphospholipid Syndrome (APS) Program is an interdisciplinary collaboration to facilitate care, education, and research around APS, an autoimmune disorder that can be associated with other rheumatic diseases, including lupus.
APS is a systemic disorder that can affect any organ or tissue. APS affects women more frequently than men and may cause problems during pregnancy, clotting or blood disorders, or may occur with other autoimmune conditions, such as lupus. We work with obstetricians, hematologists, rheumatologists, and other specialists to provide comprehensive care of all aspects of APS.
Our Approach
Patient education is essential for any chronic condition, but especially for APS patients because it is a rare disorder that has only been recognized recently. We also educate physician colleagues to raise awareness of APS and work collaboratively with them to provide coordinated care.
Fact Sheets
- Score: 1
- Score: 0
News
- Score: 1Family Health
- Score: 0Research & Innovation
